We are actively exploring opportunities to strengthen our presence in European, Southeast Asian, Middle East, and LATAM markets

Jaynil Doshi, Head - Techno Commercial, Pioma shares insights into Pioma'a growth strategy, investments in technology, global expansion plans, and long-term vision for the next decade, in an exclusive interview with Express Pharma

- 

How do you envision the role of M/s Pioma evolving in response to advancements in the pharmaceutical and cosmeceutical industries?

At M/s Pioma, we are committed to aligning our offerings with the dynamic advancements of both the pharmaceutical and cosmeceutical sectors. As these industries increasingly embrace personalised medicine, clean beauty trends, and high-performance active ingredients, we see our role expanding from a traditional ingredient supplier to a strategic innovation partner. By staying attuned to emerging technologies and scientific breakthroughs, we aim to co-create value with our clients through customised solutions, cutting-edge ingredients, and robust regulatory support.

What are the primary growth drivers for M/s Pioma in the current market, and how do you plan to leverage them over the next few years?